Hybrid neurotoxins and uses thereof
US10688162B2 · kind B2 · utility
1Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2018 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Jan 10, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to chimeric neurotoxins and uses thereof. In particular, provided herein are chimeric botulinum neurotoxins with altered properties and uses thereof (e.g., research, screening, and therapeutic uses).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.